{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-316766","form_type":"8-K","ticker":"FBRX","cik":"0001419041","company_name":"Forte Biosciences, Inc.","filed_at":"2026-07-27T10:06:03+00:00","discovered_at":"2026-07-27T10:10:00.302127+00:00","generated_at":"2026-07-27T10:10:21.508537+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"argenx to acquire Forte Biosciences for $77/share (~$2.2B); adds anti-CD122 antibody FB102","bullets":["argenx to acquire Forte Biosciences for $77/share in cash, total equity value ~$2.2B.","Offer price represents ~86% premium to Forte's VWAP since positive Phase 1b vitiligo data on July 9, 2026.","Acquisition adds first-in-class anti-CD122 antibody FB102 with clinical proof-of-concept in vitiligo and celiac disease.","Forte board unanimously recommends; tender offer requires majority of shares tendered and HSR clearance.","Supporting stockholders (directors/officers) owning ~1% of shares have agreed to tender."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-316766","json":"https://secwatch.observer/filing/0001193125-26-316766.json","markdown":"https://secwatch.observer/filing/0001193125-26-316766.md","text":"https://secwatch.observer/filing/0001193125-26-316766.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419041/000119312526316766/0001193125-26-316766-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419041/000119312526316766/d31466d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-27T10:10:21.508537+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}